Interns continue to make tough choices

Published Date: 02 Mar 2023

The Medscape Ethics Survey investigated how internal medicine physicians view the ethical aspects of the response to medical assistance in dying, gender-related publications and materials.

Read Full News

Latest News

Optimizing DPYD Testing Prior to Fluoropyrimidine Therapy

A PDSA-driven QI project cut DPYD testing turnaround from 16.7 to 12.7 days, though "expedite" order comments alone showed little added benefit.

Syngeneic Modeling of Diet-Driven Liver Cancer

New mouse model of MASLD-driven liver cancer shows sex-based tumor onset and responds to FOG-001, a first-in-class Wnt/β-catenin inhibitor.

VA Dashboards for Clinical Pathway & Genetic Testing Use

New VA dashboards tracking Clinical Pathway adherence helped raise lung cancer testing documentation from 57% to 76% and treatment templates to 42%.

Melanoma Clinical Pearls: 5 Core Principles

Are you up to date on excision margins, sentinel node candidacy, and hereditary risk? Review five critical clinical nuances to refine your approach to melanoma care.

Q&A: Melanoma Clinical Guidance

Do you know the current guidelines for suspicious lesion workups, pathology drivers, and targeted imaging? Explore key diagnostic and management questions shaping modern melanoma care.

Woman’s 3-Year Lip Swelling Reveals Granulomatous Cheilitis

A chronic, painless lip swelling proved diagnostically challenging until histology showed epithelioid granulomas and excluded infection and sarcoidosis.

Todays Updates

Conference Preview: 2026 GOLD International COPD Conference Tim Smith

HCPLive previews GOLD 2026 in Philadelphia, November 5-6, with sessions on the 2027 GOLD Report, mucus plugging, and exacerbations, plus expert interviews.

7 Pulmonology Headlines You Missed in October

7 Pulmonology Headlines You Missed in October

Nasal mRNA ETH47 Lowers Rhinovirus Load in Asthma Challenge Study

Nasal mRNA ETH47 Lowers Rhinovirus Load in Asthma Challenge Study

Q&A: Why 70% of COPD Goes Undiagnosed, With Alvar Agustí, MD

Q&A: Why 70% of COPD Goes Undiagnosed, With Alvar Agustí, MD

Mucus Plugs in COPD: Prevalence, Exacerbations, Mortality Risk

Mucus Plugs in COPD: Prevalence, Exacerbations, Mortality Risk

Analyzing Inebilizumab’s Durable Benefit in MINT Open-Label Extension Marco Meglio

Richard Nowak, MD, director of the Yale Myasthenia Gravis Clinic and global principal investigator of the MINT trial, discusses open-label extension findings for inebilizumab, a CD19-directed B cell depleting therapy, in generalized myasthenia gravis.

Final Results Reported for EPISOD1 Trial of SOD1-ALS Gene Therapy AMT-162 Marco Meglio

uniQure presented final safety and biomarker results from the discontinued EPISOD1 trial of AMT-162, an investigational gene therapy for SOD1-associated ALS.

Todays Updates

Conference Preview: 2026 GOLD International COPD Conference Tim Smith

HCPLive previews GOLD 2026 in Philadelphia, November 5-6, with sessions on the 2027 GOLD Report, mucus plugging, and exacerbations, plus expert interviews.

7 Pulmonology Headlines You Missed in October

7 Pulmonology Headlines You Missed in October

Nasal mRNA ETH47 Lowers Rhinovirus Load in Asthma Challenge Study

Nasal mRNA ETH47 Lowers Rhinovirus Load in Asthma Challenge Study

Q&A: Why 70% of COPD Goes Undiagnosed, With Alvar Agustí, MD

Q&A: Why 70% of COPD Goes Undiagnosed, With Alvar Agustí, MD

Mucus Plugs in COPD: Prevalence, Exacerbations, Mortality Risk

Mucus Plugs in COPD: Prevalence, Exacerbations, Mortality Risk

Analyzing Inebilizumab’s Durable Benefit in MINT Open-Label Extension Marco Meglio

Richard Nowak, MD, director of the Yale Myasthenia Gravis Clinic and global principal investigator of the MINT trial, discusses open-label extension findings for inebilizumab, a CD19-directed B cell depleting therapy, in generalized myasthenia gravis.

Final Results Reported for EPISOD1 Trial of SOD1-ALS Gene Therapy AMT-162 Marco Meglio

uniQure presented final safety and biomarker results from the discontinued EPISOD1 trial of AMT-162, an investigational gene therapy for SOD1-associated ALS.

Latest News

A PDSA-driven QI project cut DPYD testing turnaround from 16.7 to 12.7 days, though "expedite" order comments alone showed little added benefit.

New mouse model of MASLD-driven liver cancer shows sex-based tumor onset and responds to FOG-001, a first-in-class Wnt/β-catenin inhibitor.

New VA dashboards tracking Clinical Pathway adherence helped raise lung cancer testing documentation from 57% to 76% and treatment templates to 42%.

Are you up to date on excision margins, sentinel node candidacy, and hereditary risk? Review five critical clinical nuances to refine your approach to melanoma care.

Do you know the current guidelines for suspicious lesion workups, pathology drivers, and targeted imaging? Explore key diagnostic and management questions shaping modern melanoma care.

A chronic, painless lip swelling proved diagnostically challenging until histology showed epithelioid granulomas and excluded infection and sarcoidosis.

News All Time

A Woman on Ruxolitinib Had TB That Mimicked Metastases

A woman receiving ruxolitinib for polycythemia vera developed disseminated tuberculosis despite a negative IGRA, highlighting the limits of screening.

Pediatric Gastroenterology Faces AI Reality Check

From nutrition screening to IBD monitoring, AI shows promise in pediatric gastroenterology — yet experts stress pediatric validation is essential.

Hidradenitis Suppurativa–Associated Squamous Cell Carcinoma

Four cases highlight the aggressive nature of cutaneous squamous cell carcinoma arising in chronic perianal and gluteal hidradenitis suppurativa.

FDA Neurology Digest: August 2026

A monthly snapshot of FDA activity involving therapies used in the prevention, diagnosis, and treatment of neurologic conditions.

Sentinel Lymph Node Biopsy De-Implementation in Women Veterans

This study sought to quantify low-value sentinel lymph node biopsy practices among populations eligible for a de-escalated surgical approach in VA.

Expanding Access to Pediatric Dermatology Through Store-and-Forward Teledermatology

A pediatric dermatology–specific store-and-forward service can enhance access to specialty expertise, support care coordination, and integrate into clinical practice without increasing consultant workload.

Informed-Consent Gaps in Prostate Cancer Genetic Testing

Are oncologists missing key details during genetic testing consent? Dr Maurie Markman reviews new data and why current informed consent falls short.

Kratom: An Emerging Cause of Drug-Induced Hyperpigmentation

Kratom is an increasingly common environmental exposure with potential dermatologic consequences. Learn to recognize its association with hyperpigmentation.

Rethinking Laboratory Screening for Patients Receiving Biologics

Do all patients on biologics need routine laboratory screening? A risk-based approach can help clinicians determine when testing is truly worthwhile.

CCND1-Negative Mantle Cell Lymphoma With Balanced CCND3-IGH Rearrangement: Case Report and Literature Review

CCND1-Negative Mantle Cell Lymphoma With Balanced CCND3-IGH Rearrangement: Case Report and Literature Review

Development of a National Hematology Program: Advancing Classical Hematology Care for Veterans

Many classical (nonmalignant) hematologic disorders—including venous thromboembolism (VTE), sickle cell trait, bleeding or clotting disorders, G6PD deficiency, and others—have a propensity to manifest under physical stress or trauma.

Solitary Tender Nodule on the Forearm

A 36-year-old woman presented to the dermatology department with a nodule on the left forearm. What’s your diagnosis?

S1 Episode 4: How Early Is Early Enough to Reverse MASLD?

Drs VanWagner and Chen discuss whether fatty liver is reversible, weight-loss targets, diet quality, exercise, and where GLP-1s and bariatric surgery fit into MASLD treatment.

Teen With a Slowly Enlarging Annular Hyperkeratotic Papule

The lesion initially appeared as a small papule and gradually enlarged, with more noticeable growth in recent months. The lesion was not painful, pruritic, or bleeding.

ArteraAI: Current Indications in Prostate Cancer

From localized disease to recurrence, where can ArteraAI add actionable insight for patients with prostate cancer?

Thyroid Surgery: Practical Strategies for Optimal Post-op Care

Drs Kaniksha Desai and Michael Yeh discuss practical aspects of postoperative thyroid surgery care.

Recommended News For You

Personalized Breast Cancer Treatment; Insights Into HPV in Men; Exercise and Cancer

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

After three years, responses to mounetuzumab in follicular lymphoma are still stable.

Subcutaneous Toripalimab Matches IV Formulation in NSCLC

Formaldehyde releasers found in common personal care products used especially by Black and Latina women

Studies point to redlining as a 'perfect storm' for breast cancer

Since 2000, the outlook for multiple myeloma has improved.

Recommended Articles For You

Cerebrospinal Fluid Metabolite Biomarkers in Central Nervous System Tumor Monitoring: A New Frontier 

Emerging Therapies Through Artificial Bone Marrow Niche Engineering 

Exposure Modeling in Hematologic Malignancies: Advances, Clinical Implications, and Future Directions 

Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers investigate risk of developing multiple primary cancers after surviving bowel cancer

2.

When a Groundbreaking Cancer Therapy Causes Cancer.

3.

An inadvertent loss of weight may be an indication to consult a physician, according to research.

4.

Belzutifan Combo Could be Second-Line Option in Advanced RCC

5.

Extended lymphadenectomy has no survival benefit in patients with muscle-invasive bladder cancer.

1.

Digital Oral Oncology Care Pathways

2.

Bone Marrow Niche Dysregulation in Hematologic Disorders

3.

Exploring the Causes and Treatments of Thrombocytopenia: A Comprehensive Guide

4.

Radiation in Oncology: Advances, Applications, and Accessibility

5.

Cancer Care Access Across Communities: Epidemiology, Clinical Insights, and Emerging Solutions

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

Teaching Coagulation Pathways Through Interactive Thrombin Generation Models

2.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

3.

The Role of Platelets in Normal Blood Clotting

4.

Understanding the Difference Between Iron Deficiency and Other Types of Anemia

5.

Updates on Standard V/S High Risk Myeloma Treatment


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot